Hepatic histology in obese patients undergoing bariatric surgery
- PMID: 16899321
- DOI: 10.1016/j.jhep.2006.06.013
Hepatic histology in obese patients undergoing bariatric surgery
Abstract
Background/aims: Obesity is one of the most important clinical associations with non-alcoholic steatohepatitis (NASH). Our aim was to assess the prevalence of non-alcoholic fatty liver disease (NAFLD)/NASH in morbidly obese patients and the risk factors to more aggressive liver disease in this population.
Methods: Review of available studies on prevalence of NAFLD/NASH in severely obese patients submitted to bariatric surgery.
Results: Twelve observational and transversal studies were included, with consecutive recruitment, and prospective evaluation of data, summing 1620 patients with severe obesity. Prevalence of steatosis and NASH was 91% (range: 85-98%) and 37% (24-98%), respectively, with unexpected cirrhosis in 1.7% (1-7%). NASH was not related with age or body mass index, but there was an association between male sex and NASH/hepatic fibrosis. Diabetes mellitus and insulin resistance were the conditions most frequently associated with NASH, and hypertension with advanced hepatic fibrosis.
Conclusions: There is a very high prevalence of NAFLD in asymptomatic morbidly obese patients, more than one-third presenting histological criteria for NASH. This review underscores the large variations in prevalence of NASH between studies, calling for the need for a better agreement in the use of the histological criteria.
Similar articles
-
Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.Obes Surg. 2006 Dec;16(12):1584-93. doi: 10.1381/096089206779319392. Obes Surg. 2006. PMID: 17217634
-
Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.Obes Surg. 2005 Mar;15(3):310-5. doi: 10.1381/0960892053576820. Obes Surg. 2005. PMID: 15826462
-
Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery.Obes Surg. 2006 Feb;16(2):183-8. doi: 10.1381/096089206775565122. Obes Surg. 2006. PMID: 16469221
-
Non-alcoholic steatohepatitis in children.Pediatr Transplant. 2004 Dec;8(6):613-8. doi: 10.1111/j.1399-3046.2004.00241.x. Pediatr Transplant. 2004. PMID: 15598336 Review.
-
Review article: Non-alcoholic fatty liver disease in morbidly obese patients and the effect of bariatric surgery.Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:195-201. doi: 10.1111/j.1365-2036.2007.03483.x. Aliment Pharmacol Ther. 2007. PMID: 18081662 Review.
Cited by
-
Utility of traditional and non-traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population.Lipids Health Dis. 2022 Oct 7;21(1):95. doi: 10.1186/s12944-022-01712-z. Lipids Health Dis. 2022. PMID: 36207744 Free PMC article.
-
MASLD treatment-a shift in the paradigm is imminent.Front Med (Lausanne). 2023 Dec 11;10:1316284. doi: 10.3389/fmed.2023.1316284. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38146424 Free PMC article. Review.
-
Obesity: physiologic changes and implications for preoperative management.BMC Anesthesiol. 2015 Jul 4;15:97. doi: 10.1186/s12871-015-0079-8. BMC Anesthesiol. 2015. PMID: 26141622 Free PMC article. Review.
-
Advances in the treatment of nonalcoholic fatty liver disease.Ther Adv Endocrinol Metab. 2010 Jun;1(3):101-15. doi: 10.1177/2042018810379587. Ther Adv Endocrinol Metab. 2010. PMID: 23148155 Free PMC article.
-
Insulin Protects Hepatic Lipotoxicity by Regulating ER Stress through the PI3K/Akt/p53 Involved Pathway Independently of Autophagy Inhibition.Nutrients. 2016 Apr 19;8(4):227. doi: 10.3390/nu8040227. Nutrients. 2016. PMID: 27104558 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical